On the other hand, the higher incidence of breast cancer in PD may be associated with the lack of PARKIN protein expression in cancer cells (68%) or the rare methylation of the PARKIN promoter, which reduces PARKIN expression [61]. This evidence concerns the gene PRKN and breast carcinoma.